Intractable Low glycemic index therapy Modified Atkins diet a b s t r a c t This review highlights the current consensus guidelines regarding use of dietary therapy in childhood epilepsy. Comprehensive search was done in the electronic database, journals, reference lists and dissertations related to the field. In childhood epilepsy, about one-third patients are medically refractory. Surgical resection is an effective modality only in a third of these cases. Dietary therapy causes upto 30e40% reduction in seizure frequency in drug refractory epilepsy. The various forms of dietary therapies described are ketogenic diet, modified Atkins diet and low glycemic index treatment.
various metabolic and systemic side effects described with this form of therapy. Laboratory and clinical assessment prior to initiation and periodically on therapy is recommended. A trial of dietary therapy is labeled as failure only if there is no response even after 12 weeks of therapy. There is research ongoing globally on dietary therapy with preliminary encouraging reports in status epilepticus and other neurological conditions like migraine, brain tumor and autism.
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Around one-third patients with epilepsy have medically intractable epilepsy or suffer from adverse effects of drugs of which only a third have surgically remediable lesions. 1 Medical intractability is defined as failure of 2 or more appropriately chosen antiepileptic drugs (in combination or monotherapy) given in optimal dosage to achieve sustained seizure freedom (atleast 3 times the pre-intervention inter-seizure interval or 1 year, whichever is longer). From patient's point of view, intractability depends on the effect of seizures on daily functioning and adverse effects of drugs whereas from a physician's perspective this would be governed by the accuracy of diagnosis, natural history of the epilepsy syndrome and available treatment options. 2, 3 Ketogenic diet is a mode of treatment used particularly in children with intractable epilepsy. Studies across the world have shown upto 30e40% reduction in seizure frequency with dietary therapy. 4 1.
Chronology of evolution
Fasting associated seizure control was first documented by Dr. Rawle Geylin in early twentieth century. Wilder discovered a high fat, low carbohydrate diet which could serve the same purpose and christened it ketogenic diet. With the discovery of antiepileptic drugs like phenytoin, valproate and carbamazepine, this was not a very talked about modality of antiepileptic therapy for the major part of 20th century. In 1993, a 20-monthold boy from California named Charlie was treated with ketogenic diet at the John Hopkins Hospital for his medically refractory epilepsy leading to rapid seizure freedom. The very next year saw the creation of the Charlie foundation to promote ketogenic diet related research. Various animal and human studies have been performed since in this field. Different forms of conventional and liberal dietary therapy options have come up. In numerous nonepileptic neurological conditions usefulness of dietary therapy as a treatment option is being evaluated. 5 
Biological plausibility
Although the exact mechanism of action of ketogenic diet have always eluded researchers, several hypotheses have come up. Various animal and human studies have reinforced the fact that ketone body formation is central to its mechanism of action. Ketogenesis occurs as a result of fatty acid oxidation in the liver. Acetoacetate and b hydroxybutyrate are the primary ketone bodies generated, however there is no mechanism in the liver to convert it back to fatty acids, leading to a state of net ketone bodies' production. Brain readily uses ketone body as fuel with its uptake facilitated by a monocarboxylic transport system. The enzymatic machinery mediating the breakdown of ketone bodies in the brain has maximal expression in childhood accounting for more utilization of ketone bodies. The various proposed mechanisms for its antiseizure action include carbohydrate reduction, activation of energy dependent potassium channels through mitochondrial metabolism, inhibition of mammalian target of rapamycin pathway (Mtor) and excitatory glutamatergic transmission. With carbohydrate reduction there is inhibition of glycolysis and kindling associated epileptogenesis. A very important pathway by which ketogenic diet improves mitochondrial metabolism is reduction in reactive oxygen species. The Mtor pathway is modulated by altered bioenergetics secondary to ketosis which exerts its antiseizure effect by altering dendritic spine structure, effecting neurotransmitter release, ion channel movement and synaptic protein expression. Adenosine, an endogenous anticonvulsant (modulates neuroglial interactions and synaptic plasticity) is also stimulated by ketogenic diet. 6, 7 The anticonvulsant effect of ketogenic diet is delayed by 1e2 weeks after initiation of ketosis. This is because secondary biochemical changes in the brain other than ketonemia also play a significant role in it.
The various putative pathways of anticonvulsant action of ketogenic diet have been tabulated (Table 1 ).
Composition

Classic ketogenic diet
The classic ketogenic diet, which is usually long chain triglyceride (LCT) based, is calculated in terms of ratio of grams of fat to the grams of protein plus carbohydrate (4:1) with 90% of the energy coming from fat. However the medium chain triglyceride (MCT) based has higher ketogenic potential than LCT, thus decreasing the amount of fat intake, allowing more carbohydrate and protein. 8 Efficacy studies don't show any significant difference between the two diets, however the MCT based diet have better tolerability. 9 Nearly 60% of energy comes from fat in the MCT based diet. There is associated abdominal cramps, diarrhea and vomiting. A mix of LCT and MCT with the latter contributing for 40e50% of the energy, achieves ketosis without any significant gastrointestinal side effects. Usually ratios of 3:1 and 4:1 are used. However a recent study comparing 2.5:1 to 4:1 diet in children upto 5 years of age has shown no significant difference in terms of seizure control with better adverse effect profile in the former. 10 Liquid based ketogenic diet formula mixes are coming up which will increase the applicability of ketogenic diet in infants and enterally fed children. 11,12
Modified Atkins diet
In 1970, Robert C. Atkins developed The Atkins diet for the purpose of weight loss. Although carbohydrate intake is restricted (10e20 g/day), in contrast to the ketogenic diet, it does not restrict protein intake or daily calories. It allows meals containing 65% fat, 25% protein and 10% carbohydrates with a ketogenic ratio of 1:1. 8,13
Low glycemic index therapy
In pursuit of liberalizing ketogenic diet, the fact that children on classical ketogenic diet have stable blood glucose, gave birth to the concept of low glycemic index therapy (LGIT). This form of diet allows daily carbohydrate intake upto 40 to 60 g per day with preference for those minimally affecting blood glucose levels (glycemic index <50). 8 Table 1 e Various pathways of mechanism of action of ketogenic diet. a) Carbohydrate reduction: Glycolysis and kindling associated seizure inhibition b) Activation of ATP dependent potassium channels by modulating mitochondrial metabolism: Reduction of reactive oxygen species c) Inhibition of Mtor pathway: Structural, biochemical and molecular changes at the level of synapse d) Inhibition of excitatory glutamatergic transmission e) Adenosine upregulation: Modulation of neuroglial interaction and synaptic plasticity i n t e r n a t i o n a l j o u r n a l o f e p i l e p s y 1 ( 2 0 1 4 ) 2 7 e3 5 4.
Indications and contraindications
In 2009 The International Ketogenic Diet Study Group laid down the recommendations for ketogenic diet in medically intractable epilepsy. However there are some conditions for which early initiation of dietary therapy has been proposed ( Table 2 ). 8 In GLUT-1 deficiency syndrome and pyruvate dehydrogenase deficiency, it is the treatment of choice. In both these conditions the underlying metabolic defect is bypassed as ketones provides alternative fuel to the brain. 14, 15 In various studies, syndromic epilepsies such as Dravet, Doose and West syndrome, genetic causes like Tuberous sclerosis have all shown good response to ketogenic diet. Preliminary reports have shown beneficial effect even in Lafora body disease, LandaueKleffner syndrome, Rett syndrome and subacute sclerosing panencephalitis. Anecdotally seizure improvement with ketogenic diet in cases of phosphofructokinase deficiency, glycogenosis type V and respiratory chain defects have also been reported. 8 The absolute contraindications to the use of ketogenic diet are notably lipid metabolism defect, pyruvate carboxylase deficiency and porphyria ( Table 2 ). In disorders of fatty acid oxidation, ketogenic diet and fasting would precipitate an acute life threatening metabolic crisis. Deficiency of pyruvate decarboxylase which converts pyruvate to oxaloacetate, negatively effects the functioning of Kreb cycle. In porphyria, acute crisis is precipitated as a state of carbohydrate deficiency is created. 8 Metabolic screening prior to initiation of ketogenic diet is recommended, if the patient has developmental delay, cardiomyopathy, hypotonia, exercise intolerance, myoglobinuria or easy fatigability. 8 There is no consensus guideline for use of ketogenic diet in focal epilepsies, however decisions may be taken on an individual basis. 8, 16 5.
Adverse effects
In view of the various side effects enumerated below, strict monitoring on part of the neurologist and dietician is warranted in patients on dietary therapy. 17 a) The various metabolic side effects reported are hypercholesterolemia (upto 59%), hyperuricemia (upto 26%), metabolic acidosis, hypomagnesemia, hypoalbuminemia, aminoacid deficiency, hypocalcemia and carnitine deficiency. 8,18 b) Upto half of the patients on ketogenic diet report gastrointestinal symptoms like vomiting, pain abdomen, diarrhea and constipation. 8,18 c) In upto 7% cases, renal stones have been seen, majority being urate stones. 8 d) As far as effect on growth parameters are concerned, more clarity is required through future studies. Although in one retrospective analysis it was seen that 86% of children had slowed linear growth irrespective of age, duration of diet or composition, another prospective study with more than 200 children showed that only younger children had delayed growth whereas older children grew normally. 8 e) Cardiomyopathy and prolonged QT interval have been reported. Anecdotal reports of selenium deficiency and pancreatitis are also present. 8 
6.
Prescription and maintenance 6.1.
Prediet management
Preparing the family and the child for expectations in terms of seizure reduction, need for antiepileptic medications and cognitive improvement is paramount to the overall outcome and success of dietary therapy. Local and traditional custom based factors which may act as potential barriers to administration of diet should also be discussed. The initial steps include recording the anthropometric parameters and detailed dietary history taking which includes usual preferences, dislikes and allergies. The carbohydrate status of anticonvulsant medications that the child is on should be reviewed and accordingly changes should be made.
There are various laboratory tests recommended prior to initiation of dietary therapy (Table 3) . Metabolic screening is recommended if the cause for epilepsy is still unknown or there is progressive encephalopathy. A family history of renal calculi warrants a renal ultrasound. 8 i n t e r n a t i o n a l j o u r n a l o f e p i l e p s y 1 ( 2 0 1 4 ) 2 7 e3 5 6.2.
Diet initiation
Conventionally ketogenic diet is initiated using a fasting protocol requiring hospital admission. The duration of fasting may last upto 72 h until significant urinary ketosis is achieved (urine ketones are more than 80 mg/dl), serum b hydroxybutyrate is greater than 1.5 Mm or whole blood glucose is less than 45 mg/dl. However fasting may be associated with hypoglycemia, acidosis, dehydration, nausea, vomiting, anorexia and lethargy. Once ketosis is achieved, calories are increased on a daily basis by onethird keeping the ketogenic ratio constant. In recent times a more liberal approach has found favor, which describes gradually increasing the ketogenic ratio starting from 1:1 and advancing to 4:1 within 4e5 days or earlier if significant urine ketosis is achieved. Usually significant ketosis occurs in either group within a 1 week, with the fasting group demonstrating it a bit earlier whereas the nonfasting group showing lesser adverse effects. 19 However the consensus regarding need for hospitalization is still evolving. The liberal forms of diet, viz., MAD and LGIT, can be routinely advised on an outpatient basis.
Along with dietary therapy, all patients should be started on sugar free multivitamin, trace minerals, calcium and vitamin D supplements. 8 
6.3.
In combination with other antiepileptic therapies
With regard to antiepileptic drug therapy, there are certain situations which warrant caution. These include monitoring for secondary carnitine deficiency in patients on valproate and serum bicarbonate levels if the patient is on acetazolamide, sulthiame, topiramate or zonisamide. These patients should also be assessed periodically for renal stones and can be started on empirical oral citrate therapy. Usually antiepileptics can be tapered if seizures are reasonably well controlled on dietary therapy, however, while tapering benzodiazepines and phenobarbitone one has to be cautious for seizure exacerbations. 8 Synergistic effect of ketogenic diet with vagus nerve stimulation has been reported. 20 
Maintaining a child on ketogenic diet
During the first year of therapy, a child on ketogenic diet should be followed up 3 monthly. However, in infants, cerebral palsy patients, those with growth parameters around the 5th centile, patients with compliance issues and intercurrent illnesses, early follow ups are recommended. 
Discontinuing ketogenic diet
A trial of dietary therapy is labeled as failure only after a period of 12 weeks. 21 Those with >50% seizure control are continued for atleast 2 years on dietary therapy, however patients with >90% seizure control with no significant adverse effects can continue it for even longer. Certain conditions like GLUT-1 deficiency and pyruvate dehydrogenase deficiency need lifelong therapy. Nearly 80% patients remain seizurefree amongst those who achieve complete seizure freedom, with high recurrence risk observed in patients with electroencephalographic abnormalities and lesional epilepsy. 22 Under normal circumstances, ketogenic diet is weaned off with gradual decrease in ketogenic ratio and introduction of carbohydrates. Foods with high glycemic indices are introduced only after urinary ketosis stops. In case of seizure recurrence, dietary therapy can be reintroduced with nearly 50% achieving seizure control with drugs and/or ketogenic diet. 22, 23 
7.
Efficacy of various forms of ketogenic diet 7.1.
Classic ketogenic diet
Most of the studies till date have reported that in early childhood epilepsy, after 3 months of adequate diet therapy, around 50% and 70% patients have >90% and >50% reduction in seizure frequency respectively whereas in late childhood and adolescence the figures are to the tune of 30% and 50% respectively ( Table 5 ). This is because the machinery utilizing ketone bodies in the brain are more active in the early years and there are more chances of noncompliance with increasing age. Overall around half of the patients are able to continue the diet beyond 1 year. Adding ketogenic diet to standard antiepileptic therapy results in better seizure control. 10,11,18,24e32 
Modified Atkins diet
Various prospective as well as randomized trials evaluating the efficacy of modified Atkins' diet in medically refractory epilepsy have been reported (Table 6 ). Upto 65% and 35% patients respectively have greater than 50% and 90% reduction in seizure at 6 months after initiation of dietary therapy with 80% accepting the diet well beyond 6 months. The only notable side effect reported is constipation. In view of better i n t e r n a t i o n a l j o u r n a l o f e p i l e p s y 1 ( 2 0 1 4 ) 2 7 e3 5 i n t e r n a t i o n a l j o u r n a l o f e p i l e p s y 1 ( 2 0 1 4 ) 2 7 e3 5 tolerability and acceptability, it seems to be a suitable option for refractory adolescent and adult onset epilepsies. 13,33e39 7.3.
Low glycemic index therapy
Initial efficacy data from pilot studies are encouraging ( Table 7) . Studies have shown that upto 50% patients have greater than 90% reduction in seizures and 70e80% are compliant on the diet for upto 6 months. 21, 40 In a recently completed unpublished study in India in 40 children with refractory epilepsy, upto onethird showed around 50% seizure control with nearly 90% tolerating the diet at the end of 3 months.
Ketogenic diet in status epilepticus
Ketogenic diet is evolving as a treatment option in super refractory status epilepticus. Super refractory status epilepticus is defined as recurrent or persisting status beyond 24 h on appropriate antiepileptic and anesthetic therapy. Currently ketogenic diet is considered in super refractory status epilepticus not responding to surgery and immunotherapy. There are case reports of positive response in children with fever induced refractory epileptic encephalopathy and adults with refractory status epilepticus. In two children with nonconvulsive status beneficial effect of modified Atkin's diet has been described. Recently an adult patient with super refractory status epilepticus was successfully initiated and maintained on parenteral ketogenic diet with subsequent shift to enteral preparation. 41, 42 8.
Cognitive and behavioral benefits of ketogenic diet
Prospective studies evaluating the effect of ketogenic diet on cognition are lacking. However anecdotal and parental 10 38 children, aged 6 months to 5 years, with medically intractable epilepsy Classic (4:1) versus 2.5:1 ketogenic diet
Randomized clinical trial
At three months, 58% in the 4:1 group and 63% in the 2.5:1 group had more than 50% reduction in seizures (p ¼ 0.78), 26% in the 4:1 group and 21% in 2.5:1 group became seizure-free i n t e r n a t i o n a l j o u r n a l o f e p i l e p s y 1 ( 2 0 1 4 ) 2 7 e3 5 LGIT Randomized controlled trial (control arm was patients on standard antiepileptic therapy) At 3 months, 33% (1 seizure-free) had >50% seizure reduction as compared to none in the control arm (p ¼ 0.02) 88.5% continued the diet at 3 months i n t e r n a t i o n a l j o u r n a l o f e p i l e p s y 1 ( 2 0 1 4 ) 2 7 e3 5 reports show improvement in overall cognition, behavior and alertness, better sleep patterns and improved quality of life. 43 
Ketogenic diet in conditions other than epilepsy
The ketogenic diet has various effects on the bioenergetics. The main underlying phenomena are ketone body production and decrease in blood glucose levels. Ketone bodies raise ATP levels and reduce production of reactive oxygen species through enhanced NADH oxidation and inhibition of mitochondrial permeability transition which in turn stimulates mitochondrial biogenesis and stabilizes synaptic function. Additionally calorie restriction decreases the expression of Brain derived Neurotrophic factor and its receptor tyrosine kinase b, is antiapoptotic and exhibits antiinflammatory action. Researchers are now evaluating its potential role in treatment of other neurological disorders with encouraging reports in autism, migraine, head trauma, stroke, brain tumor, amyotrophic lateral sclerosis and Alzheimer's disease. 7, 44 
Conclusion
Ketogenic diet is an effective therapy in medically intractable epilepsy. However close monitoring is required for side effects. Palatability and patient acceptability are still a reasonable issue. Liberal modifications like modified Atkins diet and low glycemic index treatment have been developed which are more acceptable and associated with lesser side effects. Liquid based ready to mix formula preparations for infants and enterally fed patients are a welcome effort in increasing its applicability. Future studies should be planned to evaluate the long term effect of the diet in terms of cognition, behavior, growth parameters and adverse effects like development of metabolic syndrome. Head on randomized trials should be planned comparing the classical ketogenic diet with MAD and LGIT.
